Page last updated: 2024-09-03

mk 0663 and malondialdehyde

mk 0663 has been researched along with malondialdehyde in 5 studies

Compound Research Comparison

Studies
(mk 0663)
Trials
(mk 0663)
Recent Studies (post-2010)
(mk 0663)
Studies
(malondialdehyde)
Trials
(malondialdehyde)
Recent Studies (post-2010) (malondialdehyde)
54917326527,8491,40513,922

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Gulapoglu, M; Salman, S; Suleyman, H; Turan, MI; Yapca, OE; Yilmaz, I1
Aksoy, M; Albayrak, A; Demirci, E; Gundogdu, C; Kurt, N; Suleyman, B1
Alp, HH; Altuner, D; Binici, O; Genç, F; Kukula, O; Kunak, CS; Kuyrukluyıldız, U; Mutlu, E; Peker, GG1
Abd El-Kader, M; Taha, RI1
Akter, KA; Alam, MA; Kabir, F; Khan, F; Lasker, S; Mamun, F; Nahar, K; Rahman, MM; Subhan, N; Yasmin, T1

Other Studies

5 other study(ies) available for mk 0663 and malondialdehyde

ArticleYear
Benefits of the antioxidant and anti-inflammatory activity of etoricoxib in the prevention of ovarian ischemia/reperfusion injury induced experimentally in rats.
    The journal of obstetrics and gynaecology research, 2014, Volume: 40, Issue:6

    Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Glutathione; Malondialdehyde; Membrane Proteins; Ovary; Peroxidase; Pyridines; Rats, Wistar; Reperfusion Injury; Sulfones

2014
The effect of etoricoxib on kidney ischemia-reperfusion injury in rats: a biochemical and immunohistochemical assessment.
    International immunopharmacology, 2014, Volume: 23, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Caspase 3; Cells, Cultured; Cyclooxygenase 2; Disease Models, Animal; Etoricoxib; Gene Expression Regulation; Humans; Kidney; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Sulfones

2014
The Effect of Etoricoxib on Hepatic Ischemia-Reperfusion Injury in Rats.
    Oxidative medicine and cellular longevity, 2015, Volume: 2015

    Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; DNA; Etoricoxib; Gene Expression Regulation; Glutathione; Glutathione Reductase; Glutathione Transferase; Liver; Male; Malondialdehyde; Oxidative Stress; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Sulfones; Superoxide Dismutase

2015
Comparative nephroprotective effects of curcumin and etoricoxib against cisplatin-induced acute kidney injury in rats.
    Acta histochemica, 2020, Volume: 122, Issue:4

    Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Blood Urea Nitrogen; Cisplatin; Creatinine; Curcumin; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Gene Expression Regulation; Glutathione; Malondialdehyde; Oxidative Stress; Rats

2020
Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet-fed rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:1

    Topics: Animals; Antioxidants; Catalase; Cyclooxygenase 2 Inhibitors; Diet, High-Fat; Etoricoxib; Glutathione; Liver; Male; Malondialdehyde; Metabolic Syndrome; Oxidative Stress; Peroxidase; Rats, Wistar; Superoxide Dismutase; Weight Gain

2021